Ph. Weller, IMPLICATIONS OF EARLY INFLAMMATION AND INFECTION IN CYSTIC-FIBROSIS -A REVIEW OF NEW AND POTENTIAL INTERVENTIONS, Pediatric pulmonology, 24(2), 1997, pp. 143-146
Airway infection and inflammation occur early in cystic fibrosis (CF)
lung disease, suggesting the need for early treatment. Our current app
roach to routine management of CF includes a comprehensive, CF center-
directed program that aims at maintaining normal nutrition and delayin
g the progression of lung disease. Regular secretion clearance, freque
nt antibiotics, and bronchodilators are commonly used. However, despit
e this early, aggressive, comprehensive management, airway inflammatio
n and infection progress. Several other recent approaches such as the
use of corticosteroids and ibuprofen to decrease inflammation, as well
as dornase alfa to thin secretions and improve pulmonary function, ar
e under investigation in young children. Other potential treatments in
clude amiloride/uridine triphosphate and hypertonic saline aerosol. Ea
rly treatment offers the promise of reducing morbidity as well as dela
ying the progression of later disease. (C) 1997 Wiley-Liss, Inc.